Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
795 studies found for:    Attention Deficit-Hyperactivity Disorder
Show Display Options
Rank Status Study
21 Unknown  The Effect of Methylphenidate Versus Placebo on State Anxiety in Children With Attention Deficit Hyperactivity Disorder.
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate
22 Completed
Has Results
An Efficacy and Safety Study of Osmotic Release Oral System (OROS) Methylphenidate in Participants With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Disorder With Hyperactivity
Intervention: Drug: Osmotic Release Oral System (OROS) Methylphenidate Hydrochloride
23 Completed Neurobiological Aspects of the Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Device: Transcranial Direct Current Stimulation;   Device: Sham
24 Completed
Has Results
Safety and Efficacy of Methylphenidate in Children With Attention-deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Methylphenidate 20 mg long-acting capsules
25 Enrolling by invitation Improving the Medication Management of Patients With Attention-Deficit Hyperactivity Disorder
Condition: Attention Deficit-hyperactivity Disorder
Intervention: Behavioral: Clinical decision support for medication titration
26 Completed Concerta and Strattera on the Executive Function in Attention Deficit Hyperactivity Disorder (ADHD) Children
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: OROS MPH;   Drug: Atomoxetine
27 Completed
Has Results
Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Atomoxetine;   Drug: Placebo
28 Active, not recruiting Cognitive-Behavioural Therapy (CBT) for Adult Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Other: CBT plus treatment as usual;   Other: Treatment as usual
29 Completed
Has Results
Effects of Methylphenidate on Cellular Abnormalities in Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder
Interventions: Drug: Extended Release Methylphenidate (Ritalin LA ) plus Behavior Therapy;   Behavioral: Behavior Therapy
30 Completed PET Scanning of Adults With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Volunteer;   Attention Deficit Hyperactivity Disorder
Intervention:
31 Completed Influence of Education on Acceptance of Treatment for Attention Deficit Hyperactivity Disorder (ADHD) Among Women
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Behavioral: Education
32 Completed
Has Results
A Long Term Post-Marketing Study on the EffIcacy and Safety of Osmotic Release Oral System (OROS) Methylphenidate on the Cognitive Functions of Attention Deficit Hyperactivity Disorder (ADHD) Participants
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Drug: Osmotic Release Oral System Methylphenidate Hydrochloride (OROS-MPH);   Other: No intervention
33 Completed A Long-Term Safety Study to Evaluate Methylphenidate HCL Tablets at Multiple Dose Levels in Adults With Attention Deficit Hyperactivity Disorder
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: methylphenidate hydrochloride extended-release tablets
34 Recruiting Follow up Treatment of Children With Attention Deficit Hyperactivity Disorder (ADHD)
Condition: Attention Deficit Hyperactivity Disorder (ADHD)
Interventions: Behavioral: Academic and Organization skills;   Behavioral: Parent Training;   Behavioral: Social Skills Training;   Drug: Long-acting stimulant
35 Completed
Has Results
A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Atomoxetine
36 Completed
Has Results
Long-Term Study of Atomoxetine in Children With Attention-Deficit/Hyperactivity Disorder (AD/HD)
Condition: Attention Deficit Hyperactivity Disorder
Intervention: Drug: Atomoxetine hydrochloride
37 Recruiting Omega-3 Fatty Acid Supplementation to Stimulants in Children With Attention Deficit Hyperactivity Disorder and Deficient Emotional Self-Regulation
Conditions: Attention Deficit Hyperactivity Disorder;   Deficient Emotional Self-Regulation
Interventions: Dietary Supplement: Omega-3 Fatty Acid;   Drug: Stimulant Medication
38 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of of JNJ-31001074 in Children (6-11 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
39 Completed A Study to Evaluate Pharmacokinetics, Safety and Tolerability After a Single Dose Administration of JNJ-31001074 in Pediatric Patients (12-17 Years) With Attention Deficit Hyperactivity Disorder (ADHD)
Conditions: Attention Deficit Hyperactivity Disorder;   Attention Deficit Disorders With Hyperactivity
Intervention: Drug: JNJ-31001074
40 Completed
Has Results
Study of Atomoxetine and OROS Methylphenidate to Treat Children and Adolescents Ages 6-17 With ADHD
Conditions: ADHD;   Attention Deficit Hyperactivity Disorder
Intervention: Drug: Atomoxetine and OROS Methylphenidate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years